Psychiatrists have responded to Robert F. Kennedy Jr.'s remarks regarding selective serotonin reuptake inhibitors (SSRIs), labeling his perspective as an oversimplification of a complex issue.
The American Psychiatric Association (APA) has pointed out that many individuals in the U.S. struggle to access comprehensive mental health care, which is essential for effective treatment.
In light of these challenges, the APA has expressed support for increased investments aimed at enhancing access to evidence-based mental health services.